Literature DB >> 16487950

Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia.

Omer Deniz1, Ergun Tozkoparan, Halil Yaman, Erdinc Cakir, Seyfettin Gumus, Omer Ozcan, Ugur Bozlar, Cumhur Bilgi, Hayati Bilgic, Kudret Ekiz.   

Abstract

BACKGROUND: In several studies, it was shown that there was a marked decrease in serum levels of HDL-C during infection and inflammation in general. In particular, a decrease in the level of serum HDL-C was also shown in pneumonia. Correlations between inflammatory markers such as acute phase proteins, cytokines and serum HDL-C levels were shown. However, there are no studies indicating a correlation between serum HDL-C levels and the radiological extent of the disease (RED) in community-acquired pneumonia (CAP). AIM: We hypothesized that there could be a relationship between serum HDL-C levels and RED in CAP.
MATERIALS AND METHODS: A case-controlled study, including 97 patients with CAP and 45 healthy subjects, was performed. Chest X-rays of CAP patients were scored for RED, and correlations were investigated between RED scores, serum lipid parameters, the erythrocyte sedimentation rate (ESR) and serum albumin levels.
RESULTS: The mean serum HDL-C level was lower in CAP patients than in controls. A significant and negative correlation between RED scores (REDS) and serum HDL-C levels was detected (r = -0.64, P = 0.0001). There were also significant correlations between REDS and other lipid parameters. Significant correlations between ESR and serum HDL-C levels and between ESR and other serum lipid parameters were also found.
CONCLUSION: It appears that serum HDL-C levels are generally lower in CAP cases than in healthy controls. Serum HDL-C levels and serum albumin levels might decrease and serum total cholesterol/HDL-C ratios and log (TG/HDL-C) values might increase proportionally with RED in CAP patients. These results might have some significance for individuals having long-standing and/or recurrent pneumonia and other cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487950     DOI: 10.1016/j.clinbiochem.2006.01.015

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  Changes in cholesterol level correlate with the course of pulmonary nontuberculous mycobacterial disease.

Authors:  Ji Young Hong; Go Eun Yang; Yousang Ko; Yong Bum Park; Yun Su Sim; Sung Hoon Park; Chang Youl Lee; Ki-Suck Jung; Myung Goo Lee
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  Key role for scavenger receptor B-I in the integrative physiology of host defense during bacterial pneumonia.

Authors:  K M Gowdy; J H Madenspacher; K M Azzam; K A Gabor; K S Janardhan; J J Aloor; M B Fessler
Journal:  Mucosal Immunol       Date:  2014-10-22       Impact factor: 7.313

3.  The association between tuberculosis and the development of insulin resistance in adults with pulmonary tuberculosis in the Western sub-district of the Cape Metropole region, South Africa: a combined cross-sectional, cohort study.

Authors:  Lauren Philips; Janicke Visser; Daan Nel; Renée Blaauw
Journal:  BMC Infect Dis       Date:  2017-08-15       Impact factor: 3.090

4.  Major Lipids and Future Risk of Pneumonia: 20-Year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort.

Authors:  Sangmee Sharon Bae; L Cindy Chang; Sharon Stein Merkin; David Elashoff; Junichi Ishigami; Kunihiro Matsushita; Christina Charles-Schoeman
Journal:  Am J Med       Date:  2020-08-16       Impact factor: 4.965

5.  Distinctive biochemical changes in pulmonary tuberculosis and pneumonia.

Authors:  Füsun Sahin; Pınar Yıldız
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

6.  Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy.

Authors:  Harindra C Wijeysundera; Maria Koh; David A Alter; Peter C Austin; Cynthia A Jackevicius; Jack V Tu; Dennis T Ko
Journal:  Open Heart       Date:  2017-12-17

7.  Metabolic Profiling in Patients with Pneumonia on Intensive Care.

Authors:  David Antcliffe; Beatriz Jiménez; Kirill Veselkov; Elaine Holmes; Anthony C Gordon
Journal:  EBioMedicine       Date:  2017-03-29       Impact factor: 8.143

8.  Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.

Authors:  Dan Wang; Ruifang Li; Juan Wang; Qunqun Jiang; Chang Gao; Juan Yang; Lintong Ge; Qing Hu
Journal:  BMC Infect Dis       Date:  2020-07-16       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.